CR1 and interstitial lung disease: Several membrane inhibitors, such as CD22 or CD35, have been found decreased on B-cells, close to a factor of 2 for CD35, especially on memory B-cells in SSc patients with peripheral vascular modified Medsger scale altered (≥1), with diffuse cutaneous SSc (dcSSc), and ILD (19, 34).